X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9468) 9468
Publication (962) 962
Book Review (217) 217
Book Chapter (54) 54
Book / eBook (41) 41
Conference Proceeding (22) 22
Magazine Article (9) 9
Dissertation (4) 4
Newsletter (3) 3
Reference (2) 2
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (5388) 5388
male (4891) 4891
humans (4509) 4509
rats (3012) 3012
index medicus (2927) 2927
female (2515) 2515
pharmacology & pharmacy (2359) 2359
neurosciences (1912) 1912
adrenergic uptake inhibitors - pharmacology (1452) 1452
adrenergic uptake inhibitors - therapeutic use (1306) 1306
psychiatry (1243) 1243
adult (1201) 1201
dose-response relationship, drug (1079) 1079
middle aged (999) 999
norepinephrine - metabolism (985) 985
mice (974) 974
rats, sprague-dawley (958) 958
in vitro techniques (917) 917
norepinephrine (783) 783
treatment outcome (762) 762
rats, wistar (726) 726
time factors (675) 675
cardiac & cardiovascular systems (668) 668
serotonin uptake inhibitors - therapeutic use (658) 658
noradrenaline (656) 656
adrenergic beta-antagonists - therapeutic use (623) 623
adrenergic alpha-antagonists - pharmacology (619) 619
aged (617) 617
physiology (610) 610
adrenergic beta-antagonists - pharmacology (591) 591
serotonin uptake inhibitors - pharmacology (588) 588
adolescent (568) 568
attention deficit disorder with hyperactivity - drug therapy (567) 567
adrenergic uptake inhibitors - adverse effects (566) 566
serotonin (558) 558
clinical neurology (557) 557
atomoxetine hydrochloride (547) 547
norepinephrine - pharmacology (523) 523
dopamine (522) 522
double-blind (519) 519
child (506) 506
adrenergic beta-agonists - pharmacology (500) 500
adrenergic alpha-agonists - pharmacology (495) 495
antidepressants (493) 493
isoproterenol - pharmacology (492) 492
biochemistry & molecular biology (486) 486
drug therapy (460) 460
article (456) 456
double-blind method (444) 444
receptors (441) 441
drug interactions (435) 435
desipramine - pharmacology (432) 432
adrenergic uptake inhibitors - administration & dosage (428) 428
heart failure (425) 425
depression (422) 422
research (411) 411
cell biology (409) 409
brain (406) 406
analysis (405) 405
cells, cultured (405) 405
rat (402) 402
rats, inbred strains (400) 400
antidepressive agents - pharmacology (398) 398
receptors, adrenergic, beta - metabolism (389) 389
medicine & public health (386) 386
dopamine - metabolism (380) 380
propylamines - therapeutic use (379) 379
calcium - metabolism (375) 375
electric stimulation (369) 369
atomoxetine (365) 365
myocardium - metabolism (363) 363
serotonin - metabolism (360) 360
brain - metabolism (358) 358
disease models, animal (354) 354
physiological aspects (354) 354
brain - drug effects (347) 347
blood pressure - drug effects (342) 342
antidepressive agents - therapeutic use (341) 341
heart rate - drug effects (327) 327
adrenergic receptors (326) 326
receptors, adrenergic, beta - drug effects (322) 322
care and treatment (321) 321
propranolol - pharmacology (314) 314
children (306) 306
behavior, animal - drug effects (305) 305
phosphorylation (303) 303
adhd (300) 300
norepinephrine - physiology (297) 297
rodents (296) 296
receptors, adrenergic - drug effects (294) 294
reserpine - pharmacology (294) 294
motor activity - drug effects (286) 286
in-vivo (283) 283
neurons (283) 283
rat-brain (282) 282
receptors, adrenergic, alpha - drug effects (282) 282
endocrinology & metabolism (280) 280
metabolism (279) 279
pharmacology (276) 276
heart (275) 275
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9334) 9334
German (58) 58
French (29) 29
Russian (28) 28
Japanese (26) 26
Spanish (24) 24
Hungarian (9) 9
Danish (7) 7
Norwegian (6) 6
Dutch (5) 5
Italian (4) 4
Chinese (3) 3
Romanian (3) 3
Swedish (3) 3
Arabic (2) 2
Finnish (2) 2
Hebrew (2) 2
Polish (2) 2
Portuguese (2) 2
Turkish (2) 2
Czech (1) 1
Korean (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Chromatography A, ISSN 0021-9673, 2007, Volume 1170, Issue 1, pp. 23 - 33
Journal Article
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 09/2016, Volume 148, pp. 84 - 91
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 2011, Volume 19, Issue 11, pp. 3451 - 3461
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 02/2006, Volume 11, Issue 2, pp. 187 - 195
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 16, pp. 1229 - 1236
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 5/2011, Volume 50, Issue 5, pp. 281 - 294
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2009, Volume 52, Issue 21, pp. 6768 - 6781
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 2006, Volume 110, Issue 2, pp. 135 - 370
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a high social cost. Depressed patients generally display... 
Antidepressant | SSRI | Multi-target | Network theory | Mood | Depression | Co-morbidity | METABOTROPIC GLUTAMATE-RECEPTOR | co-morbidity | mood | antidepressant | network theory | PROTEIN-COUPLED RECEPTORS | FORCED SWIMMING TEST | SEROTONIN REUPTAKE INHIBITORS | TREATMENT-RESISTANT-DEPRESSION | FREELY-MOVING RATS | CORTICOTROPIN-RELEASING-FACTOR | TRANSCRANIAL MAGNETIC STIMULATION | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | depression | multi-target | METHYL-D-ASPARTATE | Depressive Disorder, Major - etiology | Cyclohexanols - adverse effects | Dopamine Uptake Inhibitors - adverse effects | Depressive Disorder, Major - metabolism | Humans | Dopamine Uptake Inhibitors - therapeutic use | Nerve Net - drug effects | Drug Delivery Systems | Brain - metabolism | Drug Design | Neurons - metabolism | Drug Therapy, Combination | Neurons - drug effects | Dopamine - metabolism | Morpholines - adverse effects | Morpholines - therapeutic use | Bupropion - therapeutic use | Depressive Disorder, Major - drug therapy | Adrenergic Uptake Inhibitors - adverse effects | Antidepressive Agents - classification | Adrenergic Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Clinical Trials as Topic | Antidepressive Agents - therapeutic use | Brain - drug effects | Venlafaxine Hydrochloride | Animals | Norepinephrine - metabolism | Serotonin - metabolism | Nerve Net - metabolism | Cyclohexanols - therapeutic use | Bupropion - pharmacology | Antidepressive Agents - adverse effects | Nitrogen oxide | Drugs | Neuropeptide Y | Care and treatment | Monoamine oxidase | Corticosteroids | Neurons | Glycogen | Depression, Mental | Development and progression | Serotonin uptake inhibitors | Peptide hormones | Methyl aspartate | Synthesis | Workplace multiculturalism | GABA | Drug therapy, Combination | Health aspects | Noradrenaline
Journal Article